Unfold My Darkness || Momentum + Long-Term Investing View || Stock Analysis || Not SEBI Registered || I Share Unfiltered Updates - So Don’t Trust Me Blindly
I share mostly unfiltered updates, news, market activity, and occasional result breakdowns. These are not recommendations.
This space is more about tracking my process than building an audience. X (Twitter) is my personal research notebook (DeepTrack).
Do not rely on my posts blindly. Always do your own research before investing.
Content Overview:
1. Company Updates:
I mostly share positive developments and may skip negative news.
🔴Risk: Missing negative signals can be dangerous. Always verify both sides.
2. Quarterly Results:
I share result summaries and key highlights based on available data.
🔴Risk: May not cover complete financial context (including all negatives or one-offs). Always review full results.
3. Penny Stocks:
🔴Risk: Very high
Note: Highly volatile and prone to manipulation. Deep research is essential.
4. Illiquid Stocks:
🔴Risk: Very high
Note: Low volumes can make entry and exit difficult and impact prices.
5. Small-Cap Stocks:
🔴Risk: High
Note: High growth potential but volatile. Requires careful analysis.
6. Mid-Cap Stocks:
🔴Risk: Moderate
Note: More stable than small caps but still need due diligence.
7. Large-Cap Stocks:
🔴Risk: Relatively lower
Note: More stable, but fundamentals and valuations still matter.
Blue Jet Healthcare Limited – Signs non-binding MoU with Andhra Pradesh Economic Development Board for proposed ₹500 crore investment in a 50-acre API manufacturing facility, to be developed phase-wise.
E2E Networks Limited – ICRA upgrades credit rating to A (Positive) from A- (Stable); H1 FY27 revenue grows 375% YoY to ₹380 crore, supported by ₹1,000 crore Sovereign AI contract.
https://t.co/gW8YFEZnkK
Pennar Industries Limited – Q2 FY27 Consolidated Total Income +11.9% YoY and +16.4% QoQ; PAT +17.0% YoY and +6.6% QoQ
https://t.co/9aVeO3DBJq
🔵 Total income ₹1,029.25 Cr; revenue from operations ₹1,015.80 Cr (+12.1% YoY, +16.7% QoQ).
✅ EBITDA ₹114.81 Cr (+21.6% YoY); EBITDA margin improved to 11.15% from 10.27%.
🔵 PBT ₹50.89 Cr (+24.3% YoY, +8.7% QoQ).
🔵 PAT ₹37.76 Cr (+17.0% YoY, +6.6% QoQ).
✅ Received orders worth ₹1,430 Cr across business verticals during the last three months.
🔵 Custom Designed Building Solutions revenue grew 21.1% YoY; Diversified Engineering segment result grew 23.1% YoY.
🔴 H1 operating cash flow declined to ₹29.68 Cr from ₹115.42 Cr.
🔴 Borrowings increased to ₹1,193 Cr; cash fell to ₹69.64 Cr. Inventory and receivables also increased.
IFGL Refractories Limited – Q2FY27 Results 👍👍👍
https://t.co/xxJgiaAmJo
Q2 FY27 Revenue +13.2% YoY and +8.0% QoQ; PAT +102.7% YoY and +50.8% QoQ
🔵 Consolidated revenue ₹553.14 Cr (+13.2% YoY, +8.0% QoQ).
✅ Consolidated PAT ₹25.72 Cr (+102.7% YoY, +50.8% QoQ).
✅ PBT ₹34.03 Cr (+103.8% YoY, +47.1% QoQ).
🔵 H1 revenue ₹1,065.51 Cr (+13.0% YoY); PAT ₹42.78 Cr (+82.0%).
✅ Europe segment turned profitable at ₹0.89 Cr versus a ₹7.36 Cr loss YoY. America segment result rose 90% YoY to ₹10.60 Cr.
🔵 Indicative EBITDA proxy ₹48.85 Cr; margin improved to 8.83% from 7.77% YoY and 7.22% QoQ.
✅ H1 operating cash flow improved to ₹68.39 Cr from ₹7.87 Cr.
🔴 Part of PAT growth benefited from the cessation of goodwill amortisation; receivables and inventory increased. ₹8.32 Cr income-tax matter remains under appeal.
IZMO Limited – Q2FY27 Results 👍
https://t.co/LldiTrWWKl
Q2 FY27 Revenue +10.4% YoY and +1.5% QoQ; Adjusted PAT Shows 32.7% YoY Growth Excluding Other Income
🔵 Consolidated revenue ₹66.35 Cr (+10.4% YoY, +1.5% QoQ).
🔵 Reported PAT ₹12.50 Cr (-0.5% YoY, +2.5% QoQ).
✅ Excluding other income of ₹1.74 Cr, indicative adjusted PAT was ₹10.76 Cr, up 32.7% YoY but down 9.2% QoQ.
✅ H1 revenue ₹131.73 Cr (+13% YoY); PAT ₹24.69 Cr (+33%).
🔵 Added 107 clients in the US and 13 in Europe, including the UK.
Overall: Underlying profitability appears stronger than reported PAT growth suggests, but sequential adjusted profit declined. Monitor overseas subsidiary performance and cash conversion.